Limits...
miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence.

Rizzo M, Mariani L, Pitto L, Rainaldi G, Simili M - J. Cell. Mol. Med. (2010)

Bottom Line: Expression of microRNAs changes markedly in tumours and evidence indicates that they are causatively related to tumourigenesis, behaving as tumour suppressor microRNAs or onco microRNAs; in some cases they can behave as both depending on the type of cancer.The INK4a/ARF locus which codifies for two proteins, p19ARF and p16INK4a, plays a central role in senescence by controlling both p53 and RB.Intriguingly, both miR-20a, member of the oncogenic miR-17-92 cluster, and miR-290, belonging to the miR-290-295 cluster, are highly expressed in embryonic stem (ES) cells.

View Article: PubMed Central - PubMed

Affiliation: Laboratory of Gene and Molecular Therapy, Institute of Clinical Physiology, CNR, Pisa, Italy.

Show MeSH

Related in: MedlinePlus

Mechanism of action of TS and onco miRNAs. MiRNAs are transcribed in the nucleus and the primary transcripts (pri-miRNAs) are processed by the nuclear RNase III Drosha in cooperation with DCGR8. The resulting pre-miRNAs are exported to the cytoplasm by Exportin 5/ RanGTP and further processed into double strand intermediates by the cytosolic RNase III Dicer. Mature miRNAs are then loaded into the RNA-induced silencing complex (RISC), where they imperfectly pair with mRNA targets (typically at the 3′UTR, in the seed match sequence) to direct post-transcriptional repression by translation inhibition or mRNA destabilization. MiRNAs behave as oncogenes when they target tumour suppressor genes; conversely they can behave as TS genes when they target oncogenes. In some cases miRNAs may have a double role as TS or oncogene depending on the type of cancer.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4373484&req=5

fig01: Mechanism of action of TS and onco miRNAs. MiRNAs are transcribed in the nucleus and the primary transcripts (pri-miRNAs) are processed by the nuclear RNase III Drosha in cooperation with DCGR8. The resulting pre-miRNAs are exported to the cytoplasm by Exportin 5/ RanGTP and further processed into double strand intermediates by the cytosolic RNase III Dicer. Mature miRNAs are then loaded into the RNA-induced silencing complex (RISC), where they imperfectly pair with mRNA targets (typically at the 3′UTR, in the seed match sequence) to direct post-transcriptional repression by translation inhibition or mRNA destabilization. MiRNAs behave as oncogenes when they target tumour suppressor genes; conversely they can behave as TS genes when they target oncogenes. In some cases miRNAs may have a double role as TS or oncogene depending on the type of cancer.

Mentions: MicroRNAs (miRNAs) are non coding short 22 nt RNA molecules which have recently come to stage as important players in basic cellular functions such as cell proliferation, differentiation apoptosis and senescence [15, 16]. Interestingly, increasing evidence indicates that many disease states such as cardiovascular, neurodegenerative, liver and kidney diseases [16] as well as cancer [17] occur or are sustained by miRNA disregulation. Expression of miRNAs changes markedly in tumours [18] and an increasing body of evidence indicates that they can behave either as tumour suppressor genes (TS miRNAs) or as oncogenes (onco miRNAs) [19–21], although it is becoming clearer that some miRNAs have a double role (TS and onco miRNAs) according to the cellular context [22]. MiRNAs are negative regulators of gene expression by imperfectly pairing to sequences (named seed match) in the 3′UTR of the target mRNA and inhibiting its translation [23]: thus miRNAs may behave as oncogenes when they inhibit tumour suppressor genes, while their tumour suppressor activity is due to the inhibition of oncogenes (Fig. 1). TS miRNAs, identified as they were markedly under-expressed in tumours, have been shown to play a role both in senescence and in apoptosis (the two main tumour suppressor mechanisms). A list of the most common TS miRNAs as well as of miRNAs with a double behaviour (TS and onco miRNAs) and their relative targets is given in Table 1. It is evident that while few TS miRNAs have been shown to exert a pro-senescence activity, others target well known anti-senescence genes suggesting a possible role in senescence. One of the first discovered TS miRNAs was let-7, down-regulated in various solid tumours [19, 24]. The proto-oncogene RAS was the first validated target of let-7 [25], but recently let-7 has also been shown to have a role in senescence and aging by targeting a negative regulator of the INK4a/ARF locus, the so-called high-mobility group AT-hook 2 (HMGA2) protein [26].


miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence.

Rizzo M, Mariani L, Pitto L, Rainaldi G, Simili M - J. Cell. Mol. Med. (2010)

Mechanism of action of TS and onco miRNAs. MiRNAs are transcribed in the nucleus and the primary transcripts (pri-miRNAs) are processed by the nuclear RNase III Drosha in cooperation with DCGR8. The resulting pre-miRNAs are exported to the cytoplasm by Exportin 5/ RanGTP and further processed into double strand intermediates by the cytosolic RNase III Dicer. Mature miRNAs are then loaded into the RNA-induced silencing complex (RISC), where they imperfectly pair with mRNA targets (typically at the 3′UTR, in the seed match sequence) to direct post-transcriptional repression by translation inhibition or mRNA destabilization. MiRNAs behave as oncogenes when they target tumour suppressor genes; conversely they can behave as TS genes when they target oncogenes. In some cases miRNAs may have a double role as TS or oncogene depending on the type of cancer.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4373484&req=5

fig01: Mechanism of action of TS and onco miRNAs. MiRNAs are transcribed in the nucleus and the primary transcripts (pri-miRNAs) are processed by the nuclear RNase III Drosha in cooperation with DCGR8. The resulting pre-miRNAs are exported to the cytoplasm by Exportin 5/ RanGTP and further processed into double strand intermediates by the cytosolic RNase III Dicer. Mature miRNAs are then loaded into the RNA-induced silencing complex (RISC), where they imperfectly pair with mRNA targets (typically at the 3′UTR, in the seed match sequence) to direct post-transcriptional repression by translation inhibition or mRNA destabilization. MiRNAs behave as oncogenes when they target tumour suppressor genes; conversely they can behave as TS genes when they target oncogenes. In some cases miRNAs may have a double role as TS or oncogene depending on the type of cancer.
Mentions: MicroRNAs (miRNAs) are non coding short 22 nt RNA molecules which have recently come to stage as important players in basic cellular functions such as cell proliferation, differentiation apoptosis and senescence [15, 16]. Interestingly, increasing evidence indicates that many disease states such as cardiovascular, neurodegenerative, liver and kidney diseases [16] as well as cancer [17] occur or are sustained by miRNA disregulation. Expression of miRNAs changes markedly in tumours [18] and an increasing body of evidence indicates that they can behave either as tumour suppressor genes (TS miRNAs) or as oncogenes (onco miRNAs) [19–21], although it is becoming clearer that some miRNAs have a double role (TS and onco miRNAs) according to the cellular context [22]. MiRNAs are negative regulators of gene expression by imperfectly pairing to sequences (named seed match) in the 3′UTR of the target mRNA and inhibiting its translation [23]: thus miRNAs may behave as oncogenes when they inhibit tumour suppressor genes, while their tumour suppressor activity is due to the inhibition of oncogenes (Fig. 1). TS miRNAs, identified as they were markedly under-expressed in tumours, have been shown to play a role both in senescence and in apoptosis (the two main tumour suppressor mechanisms). A list of the most common TS miRNAs as well as of miRNAs with a double behaviour (TS and onco miRNAs) and their relative targets is given in Table 1. It is evident that while few TS miRNAs have been shown to exert a pro-senescence activity, others target well known anti-senescence genes suggesting a possible role in senescence. One of the first discovered TS miRNAs was let-7, down-regulated in various solid tumours [19, 24]. The proto-oncogene RAS was the first validated target of let-7 [25], but recently let-7 has also been shown to have a role in senescence and aging by targeting a negative regulator of the INK4a/ARF locus, the so-called high-mobility group AT-hook 2 (HMGA2) protein [26].

Bottom Line: Expression of microRNAs changes markedly in tumours and evidence indicates that they are causatively related to tumourigenesis, behaving as tumour suppressor microRNAs or onco microRNAs; in some cases they can behave as both depending on the type of cancer.The INK4a/ARF locus which codifies for two proteins, p19ARF and p16INK4a, plays a central role in senescence by controlling both p53 and RB.Intriguingly, both miR-20a, member of the oncogenic miR-17-92 cluster, and miR-290, belonging to the miR-290-295 cluster, are highly expressed in embryonic stem (ES) cells.

View Article: PubMed Central - PubMed

Affiliation: Laboratory of Gene and Molecular Therapy, Institute of Clinical Physiology, CNR, Pisa, Italy.

Show MeSH
Related in: MedlinePlus